Are Synthetic Cannabinoids (K2 / Spice) legal in New Zealand?

Legal status

Not applicable as a class status, and in New Zealand the reason cuts both ways. A controlled drug is any substance, preparation, mixture or article specified or described in Schedule 1, 2 or 3, so the phrase synthetic cannabinoids is not itself an entry and cannot be classified as one. The absence of a name from the schedules is not an answer here either: the section 2 controlled-drug-analogue definition can place a new molecule in Class C even when its spelling never appears in a schedule, and Schedule 3 Part 7 is where that route lands. A product sold as a synthetic cannabinoid can also engage the Psychoactive Substances Act 2013 as an unapproved psychoactive product. The class of any given molecule is therefore read from its own structure and its own entry, and this row cannot supply it.

Consequences if caught

Capital exposure: none. New Zealand has no death penalty, and the section 6 life ceiling is confined to Class A, so the label itself carries no life figure either. No single ceiling attaches to it at all: the constituent class controls the section 6 or section 7 maximum, and a molecule reached through the analogue limb is treated as Class C with an 8 year dealing ceiling. A molecule named in a schedule carries whatever that schedule gives it. Sale of an unapproved psychoactive product carries its own non-capital statutory penalty under the 2013 Act, which is a separate exposure again.

If prescribed or medical

Not established for a traveller. This dossier carries no country-level rule for entering New Zealand with a prescribed medicine: it records that medicines status has to be checked alongside the analogue exclusions and the Psychoactive Substances Act 2013 route, and that a court-grade conclusion can turn on the medicine exclusions, but it states no declaration requirement, no permit, no quantity allowance and no carry limit at the border, and none was researched for this cell. No placement attaches to this label, because synthetic cannabinoids names a design space rather than a substance and each molecule takes its class from its own entry or from the analogue limb. Nothing here should be read as a ruling on a lawfully prescribed and lawfully carried supply, which is a different question this cell does not answer. Settle the border question with the Ministry of Health, whose classification order implementation page this dossier cites, and with the New Zealand border authority, before travelling.

Documentation

Carry the Misuse of Drugs Act 1975 consolidation current at 20 September 2026, and carry section 2 and Schedule 3 Part 7 with it, because this is the row where a search of the named schedules is most likely to return nothing and mislead. Read the Psychoactive Substances Act 2013 as well for anything sold as a product. Carry the classification chain this finding was read against as well: the 2022 and 2025 Classification and Presumption of Supply Orders with their commencement orders, the 2024 pseudoephedrine amendment, and the 2026 Order, which was made but is not treated as law in this dossier because its own section 2 leaves commencement to the Governor-General and no commencement instrument was located by the horizon. Carry the date as well, 20 September 2026, because in New Zealand a classification order can move a substance between classes without a word of the Act changing.

Drug laws and enforcement change and vary within a country. This is not legal advice. Always confirm with New Zealand’s embassy or official drug authority before traveling; penalties can be severe, including imprisonment.